Apexigen, Inc. WarrantApexigen, Inc. Warrant
APGNW
APGNW was delisted on the 22nd of August, 2023.
10 hedge funds and large institutions have $1.31M invested in Apexigen, Inc. WarrantApexigen, Inc. Warrant in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$299K |
| 2 |
FTCM
Fir Tree Capital Management
New York
|
+$246K |
| 3 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
+$203K |
| 4 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
+$109K |
| 5 |
RCM
Rivernorth Capital Management
West Palm Beach,
Florida
|
+$101K |
Top Sellers
APGNW Hedge Fund Activity: Q1 2021 in Review
10 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) for Q1 2021, worth a combined $1.31M.
Buyers outnumbered sellers: 10 funds opened new APGNW positions and 0 closed out — a net gain of 10 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Periscope Capital, opening a new position worth an estimated $299K.
- 10 institutional investors held Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) as of Q1 2021, up from 0 in Q4 2020.
- Funds reported $1.31M of Apexigen, Inc. WarrantApexigen, Inc. Warrant stock for Q1 2021.
- 10 funds opened new Apexigen, Inc. WarrantApexigen, Inc. Warrant positions in Q1 2021 and 0 closed out, a net change of +10 holders.
- The largest Apexigen, Inc. WarrantApexigen, Inc. Warrant buyer in Q1 2021 was Periscope Capital, an estimated $299K added.
Based on aggregated 13F filings for Q1 2021.